China Anti-Cancer Association guideline for diagnosis and treatment of cancer of multiple and unknown primaries (2023 edition)

Cancer of unknown primary (CUP) and cancer of multiple primaries (CMP) are two groups of neoplasm with high heterogeneity, low incidence, limited clinical knowledge and evidence. The diagnosis and treatment of patients with CUP and CMP is challenging. With the progress in the radiology, pathology an...

Full description

Bibliographic Details
Main Author: Society of Cancer of Multiple and Unknown Primary of China Anti-Cancer Association Yuguang
Format: Article
Language:English
Published: Editorial Office of China Oncology 2023-04-01
Series:Zhongguo aizheng zazhi
Subjects:
Online Access:http://www.china-oncology.com/fileup/1007-3639/PDF/1684138000156-2080362003.pdf
Description
Summary:Cancer of unknown primary (CUP) and cancer of multiple primaries (CMP) are two groups of neoplasm with high heterogeneity, low incidence, limited clinical knowledge and evidence. The diagnosis and treatment of patients with CUP and CMP is challenging. With the progress in the radiology, pathology and genetic features of these diseases, the cooperation and development of multi-disciplinary treatment, along with the investigation of targeted and immunology treatment have updated the treatment of these patients. We intended to guide the diagnosis and treatment of patients with CUP and CMP through this guideline, providing standard guidance for the overall management of patients.
ISSN:1007-3639